beta

CELGZ

Celgene Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Market Cap:

Primary Exchange: NASDAQ

Website: http://www.celgene.com

Shares Outstanding: 0

Float:

Dividend: 0.0359 (0.06%)

Beta:

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1583 trading days

From: 2013-09-06 To: 2019-11-05

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud